We’re excited to connect with you at CPHI Milan 2026 and explore new opportunities to work together.
Whether you’re looking for a reliable CRDMO partner, exploring opportunities across your drug development program, or discussing potential collaborations, let’s meet in person.
About Sai Life Sciences
Science-led. Execution-focused. Partnership-driven.
Sai Life Sciences is an innovator-focused, integrated Contract Research, Development and Manufacturing Organization (CRDMO) partnering with pharmaceutical and biotechnology companies to advance novel drug programs from discovery to commercial manufacturing.
Our capabilities span the drug development continuum, including drug discovery, drug substance development, drug substance manufacturing, formulations, and new modalities such as peptides, ADCs, lipids, and oligonucleotides.
With scientific depth, integrated capabilities and a focus on operational excellence, we work closely with our partners to help advance complex programs with speed, reliability and clarity.
Who You Can Meet
Mabi Jaleel,
Vice President – Biology
Leads Biology at Sai Life Sciences, advancing integrated drug discovery programs from target validation to candidate selection.
Santosh Kulkarni,
Vice President – Medicinal Chemistry
Heads Medicinal Chemistry, driving lead optimization and candidate development across discovery programs.
Vamsi Madgula,
Associate Vice President – DMPK
Leads DMPK and Toxicology Services, enabling informed candidate selection through ADMET and PK expertise.
Lakshmi Iyer,
Associate Vice President – Project Management
Leads Discovery Project Management, ensuring seamless execution and delivery of complex drug discovery programs.
Topics We'll Cover
- What Integrated Drug Discovery really means—and why it matters
- How biology, medicinal chemistry, DMPK, and project management work together to accelerate discovery
- Advantages of integrated CRO partnerships over traditional service models
- Common challenges in integrated drug discovery and strategies to overcome them
- Best practices for improving collaboration, communication, and decision-making
- Future trends shaping integrated drug discovery